Class information for:
Level 1: HER2//GASTRIC CANCER//HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
13462 835 41.0 88%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
317 3       HER2//TRASTUZUMAB//CHRONIC MYELOID LEUKEMIA 39408
652 2             HER2//TRASTUZUMAB//HER 2 NEU 13568
13462 1                   HER2//GASTRIC CANCER//HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 835

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 HER2 authKW 402737 20% 6% 170
2 GASTRIC CANCER authKW 210258 34% 2% 281
3 HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 authKW 193224 4% 14% 37
4 TRASTUZUMAB authKW 187020 12% 5% 98
5 HER 2 authKW 105740 5% 7% 44
6 GASTROESOPHAGEAL CANCER authKW 73549 2% 15% 13
7 CHARITE TUMORMED CC14 address 73136 0% 100% 2
8 C ERBB 2 authKW 70142 4% 5% 36
9 GASTROESOPHAGEAL ADENOCARCINOMA authKW 65293 1% 36% 5
10 HER 2 NEU authKW 63415 6% 4% 47

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 Oncology 10432 57% 0% 479
2 Pathology 3237 18% 0% 150
3 Gastroenterology & Hepatology 2062 16% 0% 130
4 Surgery 140 9% 0% 76
5 Medical Laboratory Technology 124 2% 0% 19
6 Medicine, Research & Experimental 113 6% 0% 46
7 Cell Biology 60 6% 0% 54
8 Anatomy & Morphology 46 1% 0% 10
9 Biotechnology & Applied Microbiology 19 4% 0% 30
10 Genetics & Heredity 10 3% 0% 25

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CHARITE TUMORMED CC14 73136 0% 100% 2
2 GEORGIUS AGR STIFTUNG RUHR 48756 0% 67% 2
3 HOSP UNIV MADRID SANCHINARRO 41135 0% 38% 3
4 AFFILIATED CANC HOSPGASTR TUMOR 36568 0% 100% 1
5 AFFILIATED HOSP 2 RADIAT ONCOL 36568 0% 100% 1
6 ANAT PATHOL HEPATOGASTROENTEROL 36568 0% 100% 1
7 ANAT PATOL FM 36568 0% 100% 1
8 ARC NET MIRIAM CHERUBINI LORO 36568 0% 100% 1
9 ASTRAZENECA INNOVAT MED EARLY DEV 36568 0% 100% 1
10 AZIENDA OSPED UNIV GAETANO MARTINO 36568 0% 100% 1

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 GASTRIC CANCER 33414 3% 4% 25
2 DISEASES OF THE ESOPHAGUS 3031 1% 1% 12
3 INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS 2590 1% 1% 8
4 APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY 2446 1% 1% 10
5 BMC CANCER 1795 2% 0% 19
6 WORLD JOURNAL OF GASTROENTEROLOGY 1711 3% 0% 28
7 HISTOPATHOLOGY 1454 2% 0% 15
8 MODERN PATHOLOGY 1271 2% 0% 13
9 CELLULAR ONCOLOGY 1232 0% 1% 4
10 ONCOTARGETS AND THERAPY 1212 1% 0% 8

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 HER2 402737 20% 6% 170 Search HER2 Search HER2
2 GASTRIC CANCER 210258 34% 2% 281 Search GASTRIC+CANCER Search GASTRIC+CANCER
3 HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 193224 4% 14% 37 Search HUMAN+EPIDERMAL+GROWTH+FACTOR+RECEPTOR+2 Search HUMAN+EPIDERMAL+GROWTH+FACTOR+RECEPTOR+2
4 TRASTUZUMAB 187020 12% 5% 98 Search TRASTUZUMAB Search TRASTUZUMAB
5 HER 2 105740 5% 7% 44 Search HER+2 Search HER+2
6 GASTROESOPHAGEAL CANCER 73549 2% 15% 13 Search GASTROESOPHAGEAL+CANCER Search GASTROESOPHAGEAL+CANCER
7 C ERBB 2 70142 4% 5% 36 Search C+ERBB+2 Search C+ERBB+2
8 GASTROESOPHAGEAL ADENOCARCINOMA 65293 1% 36% 5 Search GASTROESOPHAGEAL+ADENOCARCINOMA Search GASTROESOPHAGEAL+ADENOCARCINOMA
9 HER 2 NEU 63415 6% 4% 47 Search HER+2+NEU Search HER+2+NEU
10 GASTROESOPHAGEAL JUNCTION CANCER 55984 1% 22% 7 Search GASTROESOPHAGEAL+JUNCTION+CANCER Search GASTROESOPHAGEAL+JUNCTION+CANCER

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref.
in cl.		 Shr. of ref. in
cl.		 Citations
1 PYO, JS , SOHN, JH , KIM, WH , (2016) CONCORDANCE RATE BETWEEN HER2 IMMUNOHISTOCHEMISTRY AND IN SITU HYBRIDIZATION IN GASTRIC CARCINOMA: SYSTEMATIC REVIEW AND META-ANALYSIS.INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS. VOL. 31. ISSUE 1. P. E1 -E10 47 96% 3
2 BARTLEY, AN , WASHINGTON, MK , COLASACCO, C , VENTURA, CB , ISMAILA, N , BENSON, A , CARRATO, A , GULLEY, ML , JAIN, D , KAKAR, S , ET AL (2017) HER2 TESTING AND CLINICAL DECISION MAKING IN GASTROESOPHAGEAL ADENOCARCINOMA: GUIDELINE FROM THE COLLEGE OF AMERICAN PATHOLOGISTS, AMERICAN SOCIETY FOR CLINICAL PATHOLOGY, AND THE AMERICAN SOCIETY OF CLINICAL ONCOLOGY.JOURNAL OF CLINICAL ONCOLOGY. VOL. 35. ISSUE 4. P. 446 -+ 77 65% 0
3 BARTLEY, AN , WASHINGTON, MK , VENTURA, CB , ISMAILA, N , COLASACCO, C , BENSON, AB , CARRATO, A , GULLEY, ML , JAIN, D , KAKAR, S , ET AL (2016) HER2 TESTING AND CLINICAL DECISION MAKING IN GASTROESOPHAGEAL ADENOCARCINOMA GUIDELINE FROM THE COLLEGE OF AMERICAN PATHOLOGISTS, AMERICAN SOCIETY FOR CLINICAL PATHOLOGY, AND AMERICAN SOCIETY OF CLINICAL ONCOLOGY.ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE. VOL. 140. ISSUE 12. P. 1345 -1363 76 66% 0
4 BARTLEY, AN , WASHINGTON, MK , VENTURA, CB , ISMAILA, N , COLASACCO, C , BENSON, AB , CARRATO, A , GULLEY, ML , JAIN, D , KAKAR, S , ET AL (2016) HER2 TESTING AND CLINICAL DECISION MAKING IN GASTROESOPHAGEAL ADENOCARCINOMA GUIDELINE FROM THE COLLEGE OF AMERICAN PATHOLOGISTS, AMERICAN SOCIETY FOR CLINICAL PATHOLOGY, AND AMERICAN SOCIETY OF CLINICAL ONCOLOGY.AMERICAN JOURNAL OF CLINICAL PATHOLOGY. VOL. 146. ISSUE 6. P. 647 -669 67 66% 0
5 YOSHIDA, H , YAMAMOTO, N , TANIGUCHI, H , ODA, I , KATAI, H , KUSHIMA, R , TSUDA, H , (2014) COMPARISON OF HER2 STATUS BETWEEN SURGICALLY RESECTED SPECIMENS AND MATCHED BIOPSY SPECIMENS OF GASTRIC INTESTINAL-TYPE ADENOCARCINOMA.VIRCHOWS ARCHIV. VOL. 465. ISSUE 2. P. 145 -154 40 83% 13
6 VAKIANI, E , (2015) HER2 TESTING IN GASTRIC AND GASTROESOPHAGEAL ADENOCARCINOMAS.ADVANCES IN ANATOMIC PATHOLOGY. VOL. 22. ISSUE 3. P. 194 -201 47 72% 2
7 BAYKARA, M , BENEKLI, M , EKINCI, O , IRKKAN, SC , KARACA, H , DEMIRCI, U , AKINCI, MB , UNAL, OU , DANE, F , TURKOZ, FP , ET AL (2015) CLINICAL SIGNIFICANCE OF HER2 OVEREXPRESSION IN GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS.JOURNAL OF GASTROINTESTINAL SURGERY. VOL. 19. ISSUE 9. P. 1565 -1571 35 92% 4
8 JORGENSEN, JT , HERSOM, M , (2012) HER2 AS A PROGNOSTIC MARKER IN GASTRIC CANCER - A SYSTEMATIC ANALYSIS OF DATA FROM THE LITERATURE.JOURNAL OF CANCER. VOL. 3. ISSUE . P. 137-144 36 78% 70
9 GRILLO, F , FASSAN, M , SAROCCHI, F , FIOCCA, R , MASTRACCI, L , (2016) HER2 HETEROGENEITY IN GASTRIC/GASTROESOPHAGEAL CANCERS: FROM BENCHSIDE TO PRACTICE.WORLD JOURNAL OF GASTROENTEROLOGY. VOL. 22. ISSUE 26. P. 5879 -5887 44 63% 1
10 MOORCRAFT, SY , CHAU, I , (2014) INVESTIGATIONAL THERAPIES TARGETING THE ERBB FAMILY IN OESOPHAGOGASTRIC CANCER.EXPERT OPINION ON INVESTIGATIONAL DRUGS. VOL. 23. ISSUE 10. P. 1349 -1363 53 47% 1

Classes with closest relation at Level 1


Rank Class id link
1 6321 HER2//HER 2 NEU//TOP2A
2 1328 ADVANCED GASTRIC CANCER//S 1//GASTRIC CANCER
3 5180 C ERBB 2//HER 2 NEU//P185
4 2563 TRASTUZUMAB//LAPATINIB//PERTUZUMAB
5 12234 GASTRIC CANCER//MICROSATELLITE INSTABILITY//HUMAN GASTRIC MUCIN
6 35026 M1B PROSTATE CANCER//BIOMARKER EPIDERMAL GROWTH FACTOR RECEPTOR EGFR//C ERB B 2 NEU GENE
7 4440 NIMOTUZUMAB//CETUXIMAB//EGFR
8 34628 EGF POLYMORPHISM//EPIDERMAL GROWTH FACTOR POLYMORPHISMS//CRYPTOMPHALUS ASPERSA
9 30546 NUCLEAR EGFR//EGFR FAMILY RECEPTORS//P TYR
10 2234 PANITUMUMAB//CETUXIMAB//KRAS

Go to start page